Better glycaemic control with once-weekly insulin icodec versus once-daily insulin degludec in adults with insulin-naive type 2 diabetes (ONWARDS 3)

被引：0
|
作者：
Lingvay, I. [1 ,2 ]
Asong, M. [3 ]
Desouza, C. [4 ]
Gourdy, P. [5 ,6 ]
Kar, S. [7 ]
Vianna, A. [8 ]
Vilsboll, T. [9 ,10 ]
Vinther, S. [3 ]
Mu, Y. [11 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Sch Publ Hlth, Dallas, TX 75390 USA
[3] Novo Nordisk AS, Soborg, Denmark
[4] Univ Nebraska Med Ctr, Omaha, NE USA
[5] CHU Toulouse, Toulouse, France
[6] Univ Toulouse 3, INSERM, I2MC, UMR1297, Toulouse, France
[7] Novo Nordisk Serv Ctr India Private Ltd, Bangalore, Karnataka, India
[8] Hosp Nossa Senhora Gracas, Curitiba Diabet Ctr, Dept Endocrine Dis, Curitiba, Parana, Brazil
[9] Univ Copenhagen, Steno Diabet Ctr Copenhagen, Clin Res, Herlev, Denmark
[10] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[11] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Med Ctr 1, Beijing, Peoples R China
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
8
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] No evidence of increased physical activity-related hypoglycaemia with once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes: ONWARDS 1-5
    Riddell, M. C.
    Heller, S.
    Asong, M.
    Carstensen, L.
    Watt, S. Kehlet
    Woo, V. C.
    DIABETOLOGIA, 2024, 67 : S376 - S377
  • [42] Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials
    Abuelazm, Mohamed
    Ibrahim, Ahmed A.
    Khlidj, Yehya
    Badr, Amr
    Amin, Ahmed Mazen
    Elzeftawy, Mohamad A.
    Gowaily, Ibrahim
    Elsaeidy, Ahmed Saad
    Abdelazeem, Basel
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (02)
  • [43] Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
    Bajaj, Harpreet S.
    Bergenstal, Richard M.
    Christoffersen, Andreas
    Davies, Melanie J.
    Gowda, Amoolya
    Isendahl, Joakim
    Lingvay, Ildiko
    Senior, Peter A.
    Silver, Robert J.
    Trevisan, Roberto
    Rosenstock, Julio
    DIABETES CARE, 2021, 44 (07) : 1586 - 1594
  • [44] Once-weekly Insulin Icodec as Compared to Once-daily Basal Insulins: A Meta-analysis
    Mukhopadhyay, Pradip
    Chatterjee, Purushottam
    Pandit, Kaushik
    Sanyal, Debmalya
    Ghosh, Sujoy
    ENDOCRINE PRACTICE, 2024, 30 (02) : 128 - 134
  • [45] No Evidence of Increased Physical Activity-Related Hypoglycemia with Once-Weekly Insulin Icodec vs. Once-Daily Basal Insulin in Type 1 Diabetes-ONWARDS 6
    Sourij, Harald
    Bracken, Richard M.
    Asong, Marisse
    Carstensen, Lisbeth
    Watt, Sara K.
    Philis-Tsimikas, Athena
    DIABETES, 2024, 73
  • [46] Once-Weekly Insulin Icodec versus Once-Daily Long-Acting Insulin for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Abuelazm, Mohamed T.
    Elzeftawy, Mohamed A.
    Gowaily, Ibrahim
    Badr, Amr
    Amin, Ahmed Mazen
    Ibrahim, Ahmed A.
    Elsaeidy, Ahmed Saad
    Ali, Shafaqat
    Abdelazeem, Basel
    CIRCULATION, 2023, 148
  • [47] Insulin icodec: A novel once-weekly treatment for diabetes
    Schaffner, Hannah
    Wiener, Jordyn
    Deluca, Amanda
    Genovese, Ariana
    Deeb, Alexander
    Deeb, Wasim
    Sheikh-Ali, Mae
    Sutton, David
    Gore, Ashwini
    Berner, Jason
    Huston, Jessica
    Goldfaden, Rebecca
    DIABETIC MEDICINE, 2024, 41 (10)
  • [48] Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial
    Bergenstal, Richard M.
    Weinstock, Ruth S.
    Mathieu, Chantal
    Onishi, Yukiko
    Vijayanagaram, Vishali
    Katz, Michelle L.
    Carr, Molly C.
    Chang, Annette M.
    LANCET, 2024, 404 (10458): : 1132 - 1142
  • [49] Once-weekly Insulin Icodec: An emerging treatment option for type 2 Diabetes
    Zahra, Rubab
    Tariq, Fasiha
    Ahmed, Mushood
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (08) : 1583 - 1583
  • [50] Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial
    Russell-Jones, David
    Babazono, Tetsuya
    Cailleteau, Roman
    Engberg, Susanne
    Irace, Concetta
    Kjaersgaard, Maiken Ina Siegismund
    Mathieu, Chantal
    Rosenstock, Julio
    Woo, Vincent
    Klonoff, David C.
    LANCET, 2023, 402 (10413): : 1636 - 1647
12345